U.S. Markets closed

Exelixis, Inc. (EXEL)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
24.47-3.54 (-12.64%)
At close: 4:00PM EDT
People also watch
ARRYINCYIMGNCLDXSGEN
  • M
    Marlon
    Marlon
    I saw exel had this types of drop several time in the last year but eventually recovered fairly quick. I think the drop has 3 contributors: too many stop-loss uses, day traders or short term traders scared out. This shaking out makes excellent buying opportunity as the fundamental is still solid. it shouldn't be impacted by just one analyst's $$%% rating, plus this is a out perform to perform. Good thing is a lot people monitoring this stock now have much lower entry point. good for new share holders. There will be a strong bounding back in next Monday.
  • J
    John Dsouza
    John Dsouza
    Wow this will be a great oppty for new investors to get in and for longs to add.
  • A
    Alex
    Alex
    adding 40% here at 24.2, remember, no debt in this company. Great opportunity, great growth prospects, patience....
  • J
    John Dsouza
    John Dsouza
    This drop is not due to sale by CEO (that's over a week old). Also, the downgrade wouldn't cause a 12% drop just like the RBC upgrade didn't create a 12% rise either. Something else going on.....we'll find out soon. I still believe we'll be back above $28 by early next week and wouldn't be shocked if we get positive news out of the company to offset the downgrade and help the share price!
  • K
    Kathleen Lent
    Kathleen Lent
    I don't understand this dropping like a rock from the top of a skyscraper but I'm taking this buying opportunity
  • A
    Anonymous
    Anonymous
    I lost 5k today I'm scared should I sell Monday?
  • T
    Tonicwater27
    Tonicwater27
    It seems like nobody wants to post about the obvious disregard of the stockholders by these 2 execs selling $11,000,000 in stock options at the same time. Yes, someone said that might have needed the money. I see it as self serving greed with total disregard as to how it would effect the stock price.
    Maybe I'm just synical, but they cost me over $30K.
  • T
    Truth_Hurts
    Truth_Hurts
    Similar drop had happened at least 5 times in the past. Big deal.
  • t
    tim
    tim
    Would love to see CEO drop some big news at Monday's Cantor Fitz. HealthCare Conf.! Today's sell off on par with May's drawdown from $23's to $18's, I've been patiently waiting for this opportunity to add.
  • B
    B
    B
    Target price is $34 according to Barron's.
  • B
    Big M
    Big M
    All out assault to get the price down. Only 1m shares so don’t panic they are out of fake shares. Someone want to start a stampede to collect some cheap share of this heavily invested retail stock. Average joe investors normally don’t make this kind of cash. Big boys want in at a good price. Remember the last attack a few weeks ago. We bounced back.
  • R
    RNoble33
    RNoble33
    12% OFF Sale today for anyone interested in a great investment. It wont be here long.
  • B
    Big M
    Big M
    BMY is set to play dirty. But it will backfire. I am sure they are paying for these constant negative news clips on EXEL. What changed? Last month tons of great possible news, now the they got caught cheating. The negative news comes daily. Stay strong and long it want work BMY.
  • D
    Don1
    Don1
    Analyst making room for his buddies.
  • p
    paul
    paul
    How much SHARES do the CEO AND CFO STILL OWN AFTER SALES? Appreciate input
  • B
    Biogemfinder
    Biogemfinder
    How many times have we seen this movie? You don't have to look too far . Once in early Sept and once in early July. This is not counting many before that. Just so happens that HCC data and earnings are approaching and cheap shares were needed. Also such misinfo to suppress stock price is commonly used by BP to negotiate deals and buyouts
  • J
    John Dsouza
    John Dsouza
    CEO stock sale is old news from last week (Barron's just catching up). Motley Fool also picks on EXEL this morning to make a point about Warren Buffet. To me all this means is EXEL is clearly on the radar and there are parties out there looking to get cheap shares by scaring the weak hands. Sorry boys and girls but the EXEL investors know what they have and won't be giving up their shares cheaply as everyone knows where this mid-size, profitable, debt-free, 3 approved products, biotech is going......much more higher from here!! Good try though......
  • B
    Biogemfinder
    Biogemfinder
    Nothing has changed except this weird downgrade from outperform to market perform with PT at 28! Now the price is 24 in reaction. Of course it does not make any sense. Looks like a coordinated attack to wipe out all the stop losses and scoop shares ahead of HCC data and earnings release.I w ish I had some dry powder but if it goes down any further I am selling my other assets to load up some more. As many have pointed out the potential hasn't changed and this Leerink guy just wants to be a contrarian on the off chance that is is correct for whatever reason. We will see in next 2 weeks..about when the pps should recover or excced the closing price yesterday...
  • t
    ttsvo
    ttsvo

    FDA granted accelerated approval to Opdivo for second line HCC indication today..
    https://www.sitcancer.org/aboutsitc/press-releases/2017/nivolumab-hcc

    Oncology News Burst from FDA: Nivolumab - Society for Immunotherapy of Cancer (SITC)
    www.sitcancer.org
  • N
    Neilio
    Neilio
    Something is up. Plus the executives selling this week smells. We'll see. I have held this for 7 years. Just a little concerned without any news.